Quick Takeaways: Why It Matters? Pawsible Ventures is positioning itself as the “infrastructure VC” for pet health, and this eight‑company debut cohort shows what that means in practice: e‑prescribing rails (VetHubRx), AI clinic copilots (NxVET, PupPilot), preventive‑...
Quick Takeaways: Why It Matters? Waltham Petcare is moving canine dentistry from “late detection” to early prediction by rolling out an explainable AI risk model that uses a hybrid causal Bayesian network to flag dogs at high risk of periodontal disease befo...
Quick Takeaways: Why It Matters? Kennel Connection is turning routine pet care venues into access points for clinical‑grade diagnostics by embedding Petwealth’s at‑home PCR testing and AI insights directly into its management software used by thousands ...
Quick Takeaways: Why It Matters? PetMeds is effectively white‑labeling its online pharmacy stack for Rural King, turning a farm‑and‑ranch retailer into a full pet‑pharmacy destination across stores and digital channels. PetMeds’ first&nb...
Quick Takeaways: Why It Matters? AKC Canine Health Foundation is elevating canine geroscience from scattered projects to a focused Aging program, anchored by new global guidelines that standardize how vets diagnose and monitor Canine Cognitive Dysfunction Sy...
Quick Takeaways: Why It Matters? BiomEdit’s new patents effectively lock up its engineered Lactobacillus reuteri pvAb platform, giving it composition‑of‑matter and methods‑of‑use protection around BE‑101 and future in situ biologic payloads delivered vi...
Quick Takeaways: Why It Matters? M2 Ingredients is plugging its clinically studied, full‑spectrum mushroom portfolio into Anchor’s pet‑food customer base, effectively turning mushrooms into a ready‑to‑spec functional building block for gut, immune, and overall wellness claims i...
Quick Takeaways: Why It Matters? Gallant’s positive UMSC pilot data and FDA CVM’s expanded conditional approval eligibility together position this program as a potential first‑in‑class, disease‑modifying biologic in an almost empty feline OA toolbox. By showing up to...
Quick Takeaways: Why It Matters? BioTesserae’s BTC-001, a PD‑1–targeting single‑domain antibody for canine cancer, showed good tolerability in healthy dogs in a single‑ascending‑dose study, with doses up to three times the anticipated therapeutic level. Ins...
Quick Takeaways: Why It Matters? Lenzelta gives Boehringer Ingelheim a next‑generation mastitis vaccine that fits neatly into dry‑off protocols: two intramuscular doses in late gestation deliver early‑onset immunity and up to six months...
